Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Sun's Ready-To-Administer Chemo Drug: Compelling?

Executive Summary

Sun Pharma has started roll out of its ready-to-administer (RTA) gemcitabine in Europe, as part of plans to build a differentiated presence in oncology. Early expert opinion on the "creative tweak" appears generally encouraging and Hellen de Kloet, Sun's business head, Western Europe and Australia/New Zealand, anticipates significant switching to the new gemcitabine RTA version.



Related Companies